ToxStrategies scientist Joe Francisco has been elected to serve as president of the American College of Toxicology (ACT). Beginning December 1, 2021, he will serve one year each as vice-president, president-elect, president, and past president. Dr. Francisco is part of ToxStrategies’ Biopharmaceutical/Pharmaceutical Practice and has more than 25 years of experience in drug development, from early discovery through preclinical development.
ACT has a diverse membership including scientists in the consulting field, academia, regulatory agencies, and the pharmaceutical and biotech industries. The mission of ACT is to “educate, lead, and serve professionals in toxicology and related disciplines by promoting the exchange of information and perspectives on applied toxicology and safety assessment.”